Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Delivery of DNA-encoded vaccines and proteins in mice using cutaneous suction-mediated transfection.

FEBS open bio·2026

Same author

Acellular Normothermic Machine Perfusion Does not Exacerbate Acute Rejection in Rodent Vascularized Composite Allografts.

Transplantation direct·2026

Same author

Chronopharmacology of AAV gene therapy in mice.

microPublication biology·2025

Same author

Genetically engineered organs for early reporting of transplant rejection.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

Ex vivo machine perfusion as a platform for lentiviral gene delivery in rat livers.

Gene therapy·2025

Same author

Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing.

Human gene therapy·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Mesenchymal stem cells as therapeutics.

Biju Parekkadan¹, Jack M Milwid

¹Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Shriners Hospital for Children, and Harvard Medical School, Boston, Massachusetts 02114, USA. biju_parekkadan@hms.harvard.edu

Annual Review of Biomedical Engineering

|April 27, 2010

Summary

This summary is machine-generated.

Mesenchymal stem cells (MSCs) show promise for immune diseases. Viewing MSCs as drug carriers could enable predictive models for therapeutic efficacy, advancing stem cell treatments.

More Related Videos

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Isolation, In Vitro Expansion, and Characterization of Mesenchymal Stem Cells from Mouse Epididymal Adipose Tissue

Isolation, In Vitro Expansion, and Characterization of Mesenchymal Stem Cells from Mouse Epididymal Adipose Tissue

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Jun 13, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Isolation, In Vitro Expansion, and Characterization of Mesenchymal Stem Cells from Mouse Epididymal Adipose Tissue

Isolation, In Vitro Expansion, and Characterization of Mesenchymal Stem Cells from Mouse Epididymal Adipose Tissue

Published on: January 12, 2024

Area of Science:

Cell Biology
Immunology
Biomedical Engineering

Background:

Mesenchymal stem cells (MSCs) are multipotent cells investigated for immune-mediated diseases.
Initially recognized for skeletal repair, MSCs now demonstrate immune and tissue modulation capabilities.
Current understanding suggests MSC therapeutic effects are transient, driven by paracrine signaling.

Purpose of the Study:

To explore novel therapeutic applications of MSCs beyond tissue regeneration.
To investigate the potential of modeling MSCs as drug-delivery vehicles.
To enhance the predictability and efficacy of MSC-based therapies.

Main Methods:

Review of preclinical studies on MSC mechanisms of action.
Analysis of MSC interactions with host immune and tissue cells.
Conceptual integration of MSC biology with drug delivery principles.

Main Results:

MSC therapeutic effects are primarily mediated by short-lived paracrine interactions.
Modeling MSCs as drug-loaded particles offers a pathway to predict therapeutic outcomes.
Pharmacokinetic models can be applied to MSC transplants based on drug delivery.

Conclusions:

MSCs possess significant immunomodulatory potential for treating immune disorders.
Conceptualizing MSCs as drug carriers facilitates predictive therapeutic modeling.
Integrating MSC biology and engineering principles will drive next-generation stem cell therapeutics.